Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Emmaus Life Sciences Inc

EMMA:US

Pending Listing

Emmaus Life Sciences Inc (EMMA:US) is pending listing


Company Profile

Emmaus Holdings Inc. is engaged in the discovery, development and commercialization of treatments and therapies for rare diseases. The Company's primary focus is the late-stage development of the amino acid L-glutamine as a prescription drug for the treatment of sickle cell disease ("SCD").

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...
Advertisement
sec ||= nil